Last update 01 Nov 2024

Zentopharm GmbH

Private Company

Overview

Basic Info

Introduction
Founded in 2003, Zentopharm is dedicated to provide the life science industry with new development projects and product candidates to meet urgent needs in all major therapeutic areas as well as for medical devices and technologies. Zentopharm acquires carefully selected compounds and technologies in the range from early R&D to late clinical development and protects them by individual IPR strategies.

Related

1
Drugs associated with Zentopharm GmbH
Fosmidomycin
Target
Oxidoreductases
Mechanism
Oxidoreductases inhibitors [+1]
Active Org.-
Originator Org.
Astellas Pharma, Inc.Astellas Pharma, Inc.
Active Indication-
Inactive Indication
Malaria, Falciparum [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Zentopharm GmbH
NCT01361269
/ Unknown statusPhase 2
Multicentre Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria in African Children
100 Clinical Results associated with Zentopharm GmbH
Login to view more data
0 Patents (Medical) associated with Zentopharm GmbH
Login to view more data
100 Deals associated with Zentopharm GmbH
Login to view more data
100 Translational Medicine associated with Zentopharm GmbH
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 23 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Fosmidomycin
 ( Oxidoreductases )		Malaria, Falciparum
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free